[go: up one dir, main page]

TR200000576T1 - Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem - Google Patents

Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem

Info

Publication number
TR200000576T1
TR200000576T1 TR2000/00576T TR200000576T TR200000576T1 TR 200000576 T1 TR200000576 T1 TR 200000576T1 TR 2000/00576 T TR2000/00576 T TR 2000/00576T TR 200000576 T TR200000576 T TR 200000576T TR 200000576 T1 TR200000576 T1 TR 200000576T1
Authority
TR
Turkey
Prior art keywords
liposomal encapsulated
applying
taxane
encapsulated taxane
liposomal
Prior art date
Application number
TR2000/00576T
Other languages
English (en)
Inventor
Rahman Aquilar
Original Assignee
Neopharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neopharm filed Critical Neopharm
Publication of TR200000576T1 publication Critical patent/TR200000576T1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Kanser tedavisinde terapötik olarak gelistirilmis bir yöntemin uygulanmasinda kullanilan lipozomal kapsüllenmis taksan veya bir antineoplastik türevi veya bir karisimi saglanmaktadir. Lipozomal kapsüllenmis paclitaxel, bir toksisitle olmaksizin bir hastaya, özellikle bir insan hastaya bir saatten kisa bir sürede verilebilir.
TR2000/00576T 1998-07-01 1999-06-29 Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem TR200000576T1 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/108,509 US6146659A (en) 1998-07-01 1998-07-01 Method of administering liposomal encapsulated taxane

Publications (1)

Publication Number Publication Date
TR200000576T1 true TR200000576T1 (tr) 2000-11-21

Family

ID=22322617

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00576T TR200000576T1 (tr) 1998-07-01 1999-06-29 Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem

Country Status (17)

Country Link
US (1) US6146659A (tr)
EP (1) EP1009384A4 (tr)
JP (2) JP2001524990A (tr)
KR (1) KR20010023522A (tr)
CN (1) CN1275076A (tr)
AU (1) AU730599B2 (tr)
BR (1) BR9906581A (tr)
CA (1) CA2301057C (tr)
EA (1) EA003678B1 (tr)
HU (1) HUP0004583A3 (tr)
IL (1) IL134747A0 (tr)
NO (1) NO20001012L (tr)
NZ (1) NZ524490A (tr)
PL (1) PL338951A1 (tr)
SK (1) SK4642000A3 (tr)
TR (1) TR200000576T1 (tr)
WO (1) WO2000001366A1 (tr)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030087954A1 (en) * 1997-01-07 2003-05-08 Sonus Pharmaceuticals, Inc. Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7112338B2 (en) * 1997-03-12 2006-09-26 The Regents Of The University Of California Cationic liposome delivery of taxanes to angiogenic blood vessels
US7262173B2 (en) * 1997-03-21 2007-08-28 Georgetown University Chemosensitizing with liposomes containing oligonucleotides
US8853260B2 (en) 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US7314637B1 (en) * 1999-06-29 2008-01-01 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US6461637B1 (en) * 2000-09-01 2002-10-08 Neopharm, Inc. Method of administering liposomal encapsulated taxane
US20040006242A1 (en) * 1999-02-01 2004-01-08 Hawkins Lynn D. Immunomodulatory compounds and method of use thereof
US6835721B2 (en) * 1999-02-01 2004-12-28 Eisai Co., Ltd. Immunomodulatory compounds and methods of use thereof
US7915238B2 (en) * 1999-02-01 2011-03-29 Eisai R & D Management Co., Ltd. Immunomodulatory compounds and methods of use thereof
USRE43914E1 (en) * 1999-06-09 2013-01-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Method for detecting syphilis using synthetic antigens
CN1235567C (zh) * 1999-09-09 2006-01-11 加利福尼亚大学董事会 将紫杉烷输送到正在生成的血管的阳离子性脂质体
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
EP1259225B1 (en) * 2000-02-04 2006-10-04 Lipoxen Technologies Limited Process of dehydration/rehydration for making liposomes
US20030133972A1 (en) * 2000-10-11 2003-07-17 Targesome, Inc. Targeted multivalent macromolecules
US20030129223A1 (en) * 2000-10-11 2003-07-10 Targesome, Inc. Targeted multivalent macromolecules
KR100869824B1 (ko) 2000-11-09 2008-11-21 네오팜 인코포레이티드 Ｓｎ-38 지질 복합체 및 사용 방법
US20020073441A1 (en) 2000-12-13 2002-06-13 Ross Brian D. Compositions and methods for detecting proteolytic activity
WO2003030864A1 (en) * 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
CA2354486A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C7 ester substituted taxanes
WO2003018018A2 (en) * 2001-08-24 2003-03-06 Neopharm, Inc. Vinorelbine compositions and methods of use
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
WO2003039600A1 (en) * 2001-11-09 2003-05-15 Neopharm, Inc. Selective treatment of il-13 expressing tumors
US20030236301A1 (en) * 2001-12-19 2003-12-25 Bob Sanders Liposomal delivery of vitamin E based compounds
US20030180348A1 (en) * 2002-03-22 2003-09-25 Levinson R. Saul Transcellular drug delivery system
US7138512B2 (en) * 2002-04-10 2006-11-21 Georgetown University Gene SHINC-2 and diagnostic and therapeutic uses thereof
CA2484761C (en) 2002-05-24 2010-11-09 Angiotech International Ag Compositions and methods for coating medical implants
US20050153297A1 (en) * 2002-05-29 2005-07-14 Ateeq Ahmad Method for determining oligonucleotide concentration
WO2004006889A1 (en) * 2002-07-15 2004-01-22 Alcon, Inc. Bioerodible film for ophthalmic drug delivery
KR100533458B1 (ko) * 2002-07-20 2005-12-07 대화제약 주식회사 파클리탁셀의 가용화용 조성물 및 그의 제조 방법
AU2003268087A1 (en) * 2002-08-23 2004-03-11 Ian Ma Liposomal gemcitabine compositions for better drug delivery
JP4711947B2 (ja) * 2003-02-03 2011-06-29 ネオファーム、インコーポレイティッド 安定な濾過滅菌性リポソームに被包化されたタキサン及び他の抗腫瘍剤
EA200501285A1 (ru) * 2003-02-11 2006-02-24 Неофарм, Инк. Способ получения липосомальных препаратов
WO2004087758A2 (en) * 2003-03-26 2004-10-14 Neopharm, Inc. Il 13 receptor alpha 2 antibody and methods of use
WO2005000266A2 (en) * 2003-05-22 2005-01-06 Neopharm, Inc. Liposomal formulations comprising a combination of two or more active agents
US20060078560A1 (en) * 2003-06-23 2006-04-13 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
WO2005039533A1 (en) 2003-10-15 2005-05-06 Medigene Ag Method of administering cationic liposomes comprising an active drug
JP2007527432A (ja) 2004-03-05 2007-09-27 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド Ｃ７ラクチルオキシ置換タキサン
ES2388064T3 (es) * 2004-04-22 2012-10-08 Celator Pharmaceuticals, Inc. Formulaciones liposomales de agentes de antraciclina y análogos de citidina
JP4433918B2 (ja) * 2004-07-15 2010-03-17 コニカミノルタエムジー株式会社 画像形成方法
US20090011001A1 (en) * 2004-10-29 2009-01-08 Zafeer Ahmad Manufacturing process for liposomal preparations
CN101217946B (zh) 2004-11-02 2012-11-07 特拉维夫大学未来技术研发有限公司 水不溶性的或低水溶性药物在脂质化糖胺聚糖颗粒中的制剂和它们的制药用途
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
US20070292418A1 (en) * 2005-04-26 2007-12-20 Eisai Co., Ltd. Compositions and methods for immunotherapy
US7976852B2 (en) * 2005-04-26 2011-07-12 Eisai R&D Management Co., Ltd. Compositions and methods for cancer immunotherapy
US9233094B2 (en) 2005-05-04 2016-01-12 Medigene Ag Method of administering a cationic liposomal preparation
AU2007228984B2 (en) 2006-03-22 2012-05-03 Syncore Biotechnology Co., Ltd Treatment of triple receptor negative breast cancer
JP5199239B2 (ja) * 2006-04-20 2013-05-15 アムジエン・インコーポレーテツド 安定乳化製剤
WO2008058156A2 (en) 2006-11-06 2008-05-15 Jina Pharmaceuticals Inc. Guggulphospholipid methods and compositions
GB0905348D0 (en) 2009-03-27 2009-05-13 Ucl Business Plc Carrier
US20110070293A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Preparation of Liposomes Comprising Docetaxel
US20110070294A1 (en) * 2009-09-23 2011-03-24 Javeri Indu Methods for the Administration of Drugs Using Liposomes
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
PL226015B1 (pl) * 2011-03-03 2017-06-30 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna
WO2014092858A1 (en) 2012-12-12 2014-06-19 Temple University - Of The Commonwealth System Of Higher Education Compositions and methods for treatment of cancer
WO2014165829A2 (en) * 2013-04-05 2014-10-09 Igdrasol Nanoparticle formulations
WO2015038993A1 (en) * 2013-09-13 2015-03-19 Arbor Therapeutics, LLC Nanoparticulate compositions for targeted delivery of lipophilic drugs and acid labile, lipophilic prodrugs of cancer chemotherapeutics and their preparation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861580A (en) * 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US4812314A (en) * 1986-02-24 1989-03-14 Yissum Research & Dev. Co. Of The Hebrew Univ. Of Jerusalem And Hadassah Medical Organization Lipid replacement therapy
US4927571A (en) * 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension
EP0706373B1 (en) * 1992-03-23 2000-07-19 Georgetown University Liposome encapsulated taxol and a method of using the same
AU6833994A (en) * 1993-05-17 1994-12-12 Liposome Company, Inc., The Incorporation of taxol into liposomes and gels
JPH06329533A (ja) * 1993-05-20 1994-11-29 Kyowa Hakko Kogyo Co Ltd リポソーム製剤の製造法
US5415869A (en) * 1993-11-12 1995-05-16 The Research Foundation Of State University Of New York Taxol formulation
DE4447770C2 (de) * 1994-08-20 2002-12-19 Max Delbrueck Centrum Verfahren zur Herstellung von liposomal verkapseltem Taxol
JP4107680B2 (ja) * 1994-11-18 2008-06-25 アフィオス・コーポレーション 疎水性薬剤を含むリポソームを製造するための方法
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
TR199800443T1 (tr) * 1995-09-12 1998-06-22 The Liposome Company, Inc. Hidroliz yükseltici taksan hidrofobik türevleri.
US5756537A (en) * 1996-11-08 1998-05-26 Parkash S. Gill, M.D., Inc. Regime for paclitaxel in Kaposi's sarcoma patients

Also Published As

Publication number Publication date
CN1275076A (zh) 2000-11-29
SK4642000A3 (en) 2000-11-07
US6146659A (en) 2000-11-14
NO20001012D0 (no) 2000-02-29
NO20001012L (no) 2000-03-15
KR20010023522A (ko) 2001-03-26
HUP0004583A3 (en) 2002-04-29
NZ524490A (en) 2005-04-29
EA003678B1 (ru) 2003-08-28
AU5088099A (en) 2000-01-24
WO2000001366A1 (en) 2000-01-13
EA200000282A1 (ru) 2000-10-30
IL134747A0 (en) 2001-04-30
JP2001524990A (ja) 2001-12-04
EP1009384A4 (en) 2004-11-17
EP1009384A1 (en) 2000-06-21
BR9906581A (pt) 2000-09-26
PL338951A1 (en) 2000-12-04
CA2301057C (en) 2009-03-10
CA2301057A1 (en) 2000-01-13
JP2004059590A (ja) 2004-02-26
AU730599B2 (en) 2001-03-08
HUP0004583A2 (hu) 2001-08-28

Similar Documents

Publication Publication Date Title
TR200000576T1 (tr) Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem
ATE312635T1 (de) Ventilanordnung
AU2002236765A1 (en) Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
NO20012774D0 (no) Preparat og metode hvor det gjöres bruk av eteriske planteoljer
WO2004006842A3 (en) Combinations of drugs for the treatment of neoplasms
TR200103819T2 (tr) kanser tedavisinde ET743 terkipleri ve kullanımları
ATE329903T1 (de) Hochgradig lipophile camptothecin-derivate
DK1365808T3 (da) Sammensætninger til antitumorbehandling indeholdende ecteinascidin 743
BR0213424A (pt) Uso aperfeiçoado de composto antitumoral na terapia contra câncer
WO2004006849A3 (en) Combinations of drugs for the treatment of neoplasms
PT1085884E (pt) Combinacao de compostos seleniferos com gemcitabina ou mitomicina c
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
NO970178L (no) Terpenoidderivater (sarcodictyiner) som er nyttige som antitumormidler
NO20014812L (no) Fremgangsmate for tilveiebringelse av kosmetisk/medisinsk terapi
BR0114856A (pt) Combinação compreendendo camptotecina e um derivado de estilbeno para o tratamento de câncer
ATE233745T1 (de) Arzneistoffe
ITTO20000441A0 (it) Composizione terapeutica per la cura della psoriasi.
PT1313500E (pt) Associacoes de dalfopristina/quinupristina com o cefpirome
IT1304342B1 (it) Composizione per il trattamento cosmetico topico della cellulite.
DE60030593D1 (de) Labdan-enthaltende arzneiformulierungen zur behandlung von tumoren oder leukämien
SE9900891D0 (sv) Topical composition for dermatological and cosmetic treatment of the skin
GR1004988B (el) Λιποσωμιακο σκευασμα που περιεχει φωσφολιπιδιο, λιπιδιο και λαβδανικου τυπου διτερπενιο